Oncology Institute (DFPH) Non-Current Debt (2020 - 2026)

Oncology Institute (DFPH) has 6 years of Non-Current Debt data on file, last reported at $78.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt rose 6.38% year-over-year to $78.6 million; the trailing twelve-month figure through Mar 2026 stood at $78.6 million (up 6.38% YoY), and the FY2025 full-year result was $77.4 million, down 16.89% from the prior year.
• Non-Current Debt for Q1 2026 stood at $78.6 million, up from $77.4 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $93.1 million in Q4 2024 and bottomed at $73.9 million in Q1 2025.
• The 5-year median for Non-Current Debt is $82.1 million (2023), against an average of $82.8 million.
• The widest annual swing landed in 2023, when Non-Current Debt gained 7.82%; it then declined 16.89% in 2025.
• A 5-year view of Non-Current Debt shows it stood at $80.6 million in 2022, then climbed by 7.7% to $86.8 million in 2023, then advanced by 7.26% to $93.1 million in 2024, then slipped by 16.89% to $77.4 million in 2025, then climbed by 1.56% to $78.6 million in 2026.
• The last three Non-Current Debt figures came in at $78.6 million (Q1 2026), $77.4 million (Q4 2025), and $76.2 million (Q3 2025), per Business Quant data.

Peer Comparison